Comparing Measures of Adherence and Persistence to P2Y12 Inhibitors in Acute Coronary Syndromes

被引：0
|
作者：
Moon, Jungyeon [1 ]
Ozaki, Aya F. [2 ]
Chong, Alice [3 ]
Sud, Maneesh [4 ]
Fang, Jiming [3 ]
Austin, Peter C. [3 ]
Ko, Dennis T. [3 ,4 ,5 ]
Jackevicius, Cynthia A. [1 ,3 ,4 ,6 ]
机构：
[1] Western Univ Hlth Sci, Coll Pharm, Pomona, CA 91766 USA
[2] Univ Calif Irvine, Sch Pharm & Pharmaceut Sci, Irvine, CA USA
[3] ICES, Toronto, ON, Canada
[4] Univ Toronto, Inst Hlth Policy Management & Evaluat, Toronto, ON, Canada
[5] Sunnybrook Hlth Sci Ctr, Schulich Heart Ctr, Toronto, ON, Canada
[6] Vet Affairs Greater Los Angeles Healthcare Syst, Los Angeles, CA 90073 USA
来源：
AMERICAN JOURNAL OF CARDIOLOGY | 2024年 / 226卷
基金：
加拿大健康研究院;
关键词：
clopidogrel; ticagrelor; adherence; persistence; acute coronary syndromes; P2Y12; inhibitors;
D O I：
10.1016/j.amjcard.2024.04.047
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
[No abstract available]
引用
收藏
页码：134 / 136
页数：3
相关论文
共 50 条
  • [31] Impact of Aspirin Dosing on the Effects of P2Y12 Inhibition in Patients with Acute Coronary Syndromes
    Thomas, Mark R.
    Storey, Robert F.
    JOURNAL OF CARDIOVASCULAR TRANSLATIONAL RESEARCH, 2014, 7 (01) : 19 - 28
  • [32] Lower Mortality and Stent Thrombosis Rates Associated With Introduction of Potent P2Y12 Inhibitors in Patients With Acute Coronary Syndromes
    Iqbal, Javaid
    Rowe, Rebecca
    Zhang, Yao-Jun
    Parviz, Yasir
    Morton, Allison C.
    Grech, Ever
    Gunn, Julian P.
    Storey, Robert F.
    CIRCULATION, 2014, 130
  • [33] Viewpoint: Mismatch between the European and American guidelines on oral antiplatelet P2Y12 inhibitors after acute coronary syndromes
    Serebruany, Victor L.
    DiNicolantonio, James J.
    THROMBOSIS AND HAEMOSTASIS, 2013, 110 (01) : 5 - 10
  • [34] Pretreatment with P2Y12 Receptor Inhibitors in Acute Coronary Syndromes-Is the Current Standpoint of ESC Experts Sufficiently Supported?
    Niezgoda, Piotr
    Ostrowska, Malgorzata
    Adamski, Piotr
    Gajda, Robert
    Kubica, Jacek
    JOURNAL OF CLINICAL MEDICINE, 2023, 12 (06)
  • [35] Implications of variability in definition and reporting of major bleeding in randomized trials of oral P2Y12 inhibitors for acute coronary syndromes
    Quinlan, Daniel J.
    Eikelboom, John W.
    Goodman, Shaun G.
    Welsh, Robert C.
    Fitchett, David H.
    Theroux, Pierre
    Mehta, Shamir R.
    EUROPEAN HEART JOURNAL, 2011, 32 (18) : 2256 - 2265
  • [36] Safety of crushed/chewed P2Y12 inhibitors in acute coronary syndromes - a meta-analysis of randomized controlled trials
    Fazzini, Luca
    Pascalis, Luca
    Kirov, Hristo
    Di Franco, Antonino
    Cardoso, Rhanderson
    Moustafa, Amr Osama
    Schulze, Christian
    Treml, Ricardo E.
    Doenst, Torsten
    Caldonazo, Tulio
    CARDIOVASCULAR INTERVENTION AND THERAPEUTICS, 2025, 40 (02) : 268 - 276
  • [37] Characteristics of new P2Y12 inhibitors: selection of P2Y12 inhibitors in clinical practice
    Golino, Paolo
    JOURNAL OF CARDIOVASCULAR MEDICINE, 2013, 14 : S22 - S30
  • [38] Impact of Society Guidelines on Trends in Use of Newer P2Y12 Inhibitors for Patients With Acute Coronary Syndromes Undergoing Percutaneous Coronary Intervention
    Mohamed, Mohamed O.
    Kontopantelis, Evangelos
    Alasnag, Mirvat
    Abid, Leila
    Banerjee, Amitava
    Sharp, Andrew S. P.
    Bourantas, Christos
    Sirker, Alex
    Curzen, Nick
    Mamas, Mamas A.
    JOURNAL OF THE AMERICAN HEART ASSOCIATION, 2024, 13 (09):
  • [39] P2Y12 INHIBITOR ADHERENCE TRAJECTORIES IN PATIENTS WITH ACUTE CORONARY SYNDROME UNDERGOING PERCUTANEOUS CORONARY INTERVENTION
    Turgeon, Ricky D.
    Koshman, Sheri
    Dong, Yuan
    Graham, Michelle
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2021, 77 (18) : 16 - 16
  • [40] New P2Y12 inhibitors
    Storey, Robert F.
    HEART, 2011, 97 (15) : 1262 - 1267
12345